Brief: Maravai LifeSciences Announces Completion Of Planned CEO Leadership Transition
July 27 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* MARAVAI LIFESCIENCES ANNOUNCES COMPLETION OF PLANNED CEO
LEADERSHIP TRANSITION
* MARAVAI LIFESCIENCES HOLDINGS INC - CARL HULL TO CONTINUE
TO
SERVE AS EXECUTIVE CHAIRMAN
* MARAVAI LIFESCIENCES HOLDINGS INC - WILLIAM "TREY" MARTIN,
III
ASSUMES ROLE OF MARAVAI'S CEO
Source text for Eikon: ID:nGNX3v5QC
Further company coverage: MRVI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million